Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/03/2026 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|
| Revenue | 4M | 2M | 2M | 2M | 0 | 0 |
| Research and development | 2M | 1M | 1M | 2M | 2M | 2M |
| Selling, general and administrative | 13M | 10M | 16M | 14M | 13M | 16M |
| Operating expenses | 46M | 41M | 47M | 39M | 31M | 40M |
| Operating income | −42M | −39M | −46M | −38M | −31M | −40M |
| Interest expense | — | — | — | — | — | 12M |
| Pre-tax income | — | — | — | — | −91M | −48M |
| Income tax | — | — | — | — | 0 | 0 |
| Net income | −33M | −28M | −144M | 9M | −91M | −48M |
| Earnings per share | −0.21 | −0.19 | −0.81 | 0.05 | −0.54 | −0.29 |
| Earnings per share, diluted | −0.21 | −0.31 | −0.81 | 0.05 | −0.54 | −0.29 |
| Weighted average shares | 180M | 180M | 180M | 177M | 167M | 165M |
| Weighted average shares, diluted | 180M | 185M | 180M | 179M | 167M | 165M |
| Metric | 31/03/2026 | 31/12/2025 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 90M | 157M | 234M | 284M | 22M | 16M | 84M | 11M |
| Receivables | 4M | 2M | 2M |
| Metric | 31/03/2026 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | −43M | — | — | −39M | — | — |
| Depreciation and amortisation | 7M | 7M | 7M | 7M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 2M |
| 1M |
| 0 |
| — |
| — |
| Inventory | 12M | 9M | 11M | 11M | 9M | 8M | 7M | 6M |
| Current assets | 146M | 198M | 265M | 315M | 50M | 54M | 101M | 32M |
| Property, plant and equipment | 660M | 658M | 656M | 659M | 668M | 674M | 645M | 646M |
| Total assets | 886M | 923M | 989M | 1.04B | 787M | 798M | 789M | 720M |
| Current liabilities | 86M | 88M | 118M | 147M | 91M | 91M | 58M | 48M |
| Short-term debt | — | — | — | — | — | 13M | 11M | 4M |
| Total liabilities | 569M | 572M | 622M | 650M | 549M | 618M | 547M | 428M |
| Equity | 7M | 46M | 68M | 99M | 238M | 180M | 241M | 292M |
| Shares outstanding | 181M | 180M | 180M | 180M | 180M | 174M | 173M | 165M |
| Shares issued | 181M | 180M | 180M | 180M | 180M | 174M | 173M | 165M |
| 7M |
| 7M |
| Share-based compensation | 3M | — | — | 3M | — | — |
| Capital expenditure | 3M | — | — | 15M | — | — |
| Investing cash flow | −21M | — | — | −15M | — | — |
| Share buybacks | 2M | — | — | 2M | — | — |
| Financing cash flow | −5M | — | — | 50M | — | — |